酪氨酸激酶抑制剂舒尼替尼和索拉非尼引起的继发性红细胞增多症。 - Suppr

Suppr

超能文献

Secondary erythrocytosis produced by the tyrosine kinase inhibitors sunitinib and sorafenib.

作者信息

Alexandrescu Doru T, McClure Rebecca, Farzanmehr Haleh, Dasanu Constantin A

出版信息

J Clin Oncol. 2008 Aug 20;26(24):4047-8. doi: 10.1200/JCO.2008.18.3525.

DOI:10.1200/JCO.2008.18.3525

PMID:18711201

Abstract

摘要

相似文献

Secondary erythrocytosis produced by the tyrosine kinase inhibitors sunitinib and sorafenib.

J Clin Oncol. 2008 Aug 20;26(24):4047-8. doi: 10.1200/JCO.2008.18.3525.

Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib.

Br J Dermatol. 2009 Nov;161(5):1045-51. doi: 10.1111/j.1365-2133.2009.09290.x. Epub 2009 May 5.

Thyroid dysfunction in patients treated with tyrosine kinase inhibitors, sunitinib, sorafenib and axitinib, for metastatic renal cell carcinoma.

Jpn J Clin Oncol. 2012 Aug;42(8):742-7. doi: 10.1093/jjco/hys076. Epub 2012 May 23.

A case of acute haemolysis with 2 different multi target thyrosine kinase inhibitors in a patient with renal cancer.

Bull Soc Sci Med Grand Duche Luxemb. 2009(1):7-9.

[Medical treatment of metastatic renal cell carcinoma after the approval and market entry of multitargeted tyrosine kinase inhibitors in Germany].

Aktuelle Urol. 2009 Jan;40(1):31-6. doi: 10.1055/s-2008-1038176. Epub 2009 Jan 28.

Tyrosine kinase inhibitors in advanced renal cell carcinoma: the evolving treatment paradigm.

Clin Genitourin Cancer. 2009 Jan;7(1):9-10. doi: 10.3816/CGC.2009.n.001.

Sequential therapy with sunitinib and sorafenib in metastatic hepatocellular carcinoma.

Invest New Drugs. 2012 Aug;30(4):1768-72. doi: 10.1007/s10637-011-9707-4. Epub 2011 Jul 1.

Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib.

Ann Oncol. 2008 Nov;19(11):1955-61. doi: 10.1093/annonc/mdn389. Epub 2008 Jun 10.

Kidney cancer: Does hypothyroidism predict clinical outcome?

Nat Rev Urol. 2011 Jan;8(1):10-1. doi: 10.1038/nrurol.2010.191. Epub 2010 Nov 30.

[New drugs; sunitinib and sorafenib].

Ned Tijdschr Geneeskd. 2007 Dec 29;151(52):2888-90.

引用本文的文献

Diagnosis, management, and outcomes of drug-induced erythrocytosis: a systematic review.

Blood Adv. 2025 May 13;9(9):2108-2118. doi: 10.1182/bloodadvances.2024015410.

Front Oncol. 2024 Aug 6;14:1398055. doi: 10.3389/fonc.2024.1398055. eCollection 2024.

The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study.

Ther Adv Urol. 2023 Jul 22;15:17562872231187216. doi: 10.1177/17562872231187216. eCollection 2023 Jan-Dec.

Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma.

Cancer Chemother Pharmacol. 2023 Apr;91(4):337-344. doi: 10.1007/s00280-023-04519-6. Epub 2023 Mar 24.

Quantitative and qualitative changes in platelet traits of sunitinib-treated patients with renal cell carcinoma in relation to circulating sunitinib levels: a proof-of-concept study.

BMC Cancer. 2022 Jun 13;22(1):653. doi: 10.1186/s12885-022-09676-0.

Acute Lower Extremity Arterial Thrombosis Associated with Osimertinib-Induced Erythrocytosis.

Am J Case Rep. 2021 Sep 7;22:e932252. doi: 10.12659/AJCR.932252.

VEGFR-TKIs combined with chemotherapy for advanced non-small cell lung cancer: A systematic review.

J Cancer. 2019 Jan 30;10(4):799-809. doi: 10.7150/jca.29643. eCollection 2019.

Case: Secondary polycythemia due to pazopanib in patients with metastatic renal cell carcinoma.

Can Urol Assoc J. 2017 Nov;11(11):E449-E450. doi: 10.5489/cuaj.4519.

Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies.

J Hepatocell Carcinoma. 2017 Jul 11;4:93-103. doi: 10.2147/JHC.S106529. eCollection 2017.

Haemoglobin level increase as an efficacy biomarker during axitinib treatment for metastatic renal cell carcinoma: a retrospective study.

BMC Cancer. 2017 May 22;17(1):355. doi: 10.1186/s12885-017-3312-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验